Alkermes plc - Ordinary Shares — Cash Flow (NASDAQ:ALKS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 82.84 M101.72 M21.04 M401.35 M439.12 M520.75 M 256.2 M Cash from investing activities -11.48 M-66.2 M-64.54 M53.36 M-111.31 M295.5 M -1.79 B Cash from financing activities -2.17 M29.07 M-1.57 M-289.71 M-494.14 M12.38 M 1.49 B Free cash flow 82.84 M101.72 M21.04 M401.35 M439.12 M520.75 M 256.2 M

News

Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar?

Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?

HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase

Alkermes: "Buy" On Avadel Acquisition And Positive NT2 Data With Alixorexton (NASDAQ:ALKS)

ALKS' Sleep Disorder Drug Gets Orphan Drug Tags in the U.S. & Europe

Alkermes plc (ALKS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Why Is Revolution Medicines (RVMD) Up 9.3% Since Last Earnings Report?

Alkermes (ALKS) Up 21.1% Since Last Earnings Report: Can It Continue?

Alkermes Analysts Increase Their Forecasts Following Strong Q1 Results - Alkermes (NASDAQ:ALKS)

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

Alkermes: A Sleep Medicine Platform Hidden Inside A Mature CNS Company (ALKS)

Alkermes (ALKS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates